A-674563
|
|
552325-73-2
|
Brigatinib
|
|
1197953-54-0
|
Alectinib Hydrochloride
|
|
1256589-74-8
|
ASP3026
|
|
1097917-15-1
|
Entrectinib
|
|
1108743-60-7
|
GSK2110183 analog 1 hydrochloride
|
|
2070009-64-0
|
AT13148
|
|
1056901-62-2
|
Miransertib
|
|
1313881-70-7
|
AKT-IN-6
|
|
1430056-54-4
|
Akt1/Akt2-IN-1
|
|
893422-47-4
|
Sincalide ammonium
|
|
70706-98-8
|
Crosstide
|
|
171783-05-4
|
K-80003
|
|
1292821-90-9
|
NCT-506
|
|
2231098-99-8
|
ALDH1A1-IN-2
|
|
2231081-18-6
|
NCT-501
|
|
1802088-50-1
|
Fidarestat
|
|
136087-85-9
|
Lidorestat
|
|
245116-90-9
|
Zenarestat
|
|
112733-06-9
|
AT-007
|
|
2170729-29-8
|
Imirestat
|
|
89391-50-4
|
Tolrestat
|
|
82964-04-3
|
Caficrestat
|
|
1355612-71-3
|
Repotrectinib
|
|
1802220-02-5
|
JH-VIII-157-02
|
|
1639422-97-1
|
MS4078
|
|
2229036-62-6
|
MS4077
|
|
2230077-10-6
|
A-674563 hydrochloride
|
|
2070009-66-2
|
(E)-Akt inhibitor-IV
|
|
959841-49-7
|
PI3K/Akt/CREB activator 1
|
|
2708177-73-3
|
Ipatasertib
|
|
1001264-89-6
|
Afuresertib
|
|
1047644-62-1
|
Afuresertib hydrochloride
|
|
1047645-82-8
|
Uprosertib
|
|
1047634-65-0
|
Iruplinalkib
|
|
1854943-32-0
|
ALK inhibitor 1
|
|
761436-81-1
|
Belizatinib
|
|
1357920-84-3
|
ALK kinase inhibitor-1
|
|
1462949-64-9
|
ZX-29
|
|
2254805-62-2
|
XST-14
|
|
2607143-50-8
|
HG-14-10-04
|
|
1356962-34-9
|
UNC5293
|
|
2226789-82-6
|
AZD-3463
|
|
1356962-20-3
|
R-268712
|
|
879487-87-3
|
COG 133
|
|
514200-66-9
|
N-((Benzyloxy)carbonyl)-O-(tert-butyl)-L-threonine
|
|
16966-09-9
|
Boc-L-Tyrosine methyl ester
|
|
4326-36-7
|
Boc-Ala-NMe(OMe)
|
|
87694-49-3
|
N-(tert-Butoxycarbonyl)-S-butylhomocysteine
|
|
1396969-20-2
|
N-Fmoc-O-benzyl-L-tyrosine
|
|
71989-40-7
|
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid
|
|
623950-02-7
|
2-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid
|
|
1289942-66-0
|
N-Formyl-L-leucine
|
|
6113-61-7
|
(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate
|
|
868539-99-5
|
(S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate
|
|
1140908-89-9
|
(S)-2-amino-3-(4-benzoylphenyl)propanoic acid
|
|
104504-45-2
|
Boc-D-Leucine monohydrate
|
|
200937-17-3
|
H-Phg(4-Cl)-OH
|
|
67336-19-0
|
O-(tert-Butyl)-N-Fmoc-L-allothreonine
|
|
201481-37-0
|
tert-Butyl 2-aminoacetate
|
|
6456-74-2
|
Fmoc-Gly(allyl)-OH
|
|
146549-21-5
|
Fmoc-Lys(Mtt)-OH
|
|
167393-62-6
|
Fmoc-D-Phe(4-F)-OH
|
|
177966-64-2
|
Ipatasertib dihydrochloride
|
|
1396257-94-5
|
ALM301
|
|
1313439-71-2
|
Vevorisertib trihydrochloride
|
|
1416775-08-0
|
MKC-1
|
|
125313-92-0
|
Sorbinil
|
|
68367-52-2
|
PI3K/Akt/mTOR-IN-2
|
|
2757804-89-8
|
Zopolrestat
|
|
110703-94-1
|
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid
|
|
220497-85-8
|
Fmoc-Ala-OH
|
|
35661-39-3
|
Glycyltyrosine dihydrate
|
|
39630-46-1
|
Fmoc-Lys(Alloc)-OH
|
|
146982-27-6
|
Fmoc-Phe(3,4-DiF)-OH
|
|
198560-43-9
|
Fmoc-Asp-OtBu
|
|
129460-09-9
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid
|
|
211637-75-1
|
Fmoc-Phe(4-I)-OH
|
|
82565-68-2
|
Fmoc-L-Lys(Dde)-OH
|
|
150629-67-7
|
N6-Diazo-L-Fmoc-lysine
|
|
159610-89-6
|
Fmoc-1-methyl-L-histidine
|
|
202920-22-7
|
Fmoc-Trp(Me)-OH
|
|
1334509-86-2
|
cis-Fmoc-Pro(4-N3)-OH
|
|
263847-08-1
|
Boc-D-Asp-OBzl
|
|
92828-64-3
|
Fmoc-Asp(OtBu)-OH
|
|
71989-14-5
|
Fmoc-Arg(Pbf)-OH
|
|
154445-77-9
|
Ampalex
|
安帕來斯
|
154235-83-3
|
CNQX disodium salt
|
|
479347-85-8
|
PF-06409577
|
|
1467057-23-3
|
MK8722
|
|
1394371-71-1
|
O-304
|
|
1261289-04-6
|
EB-3D
|
|
1839150-63-8
|
HTH-01-015
|
|
1613724-42-7
|
Pep2m, myristoylated
|
|
1423381-07-0
|
CNQX
|
|
115066-14-3
|
COH-SR4
|
|
73439-19-7
|
AMPK activator 4
|
|
2493239-46-4
|
IM156
|
|
1422365-94-3
|
7-Methoxyisoflavone
|
|
1621-56-3
|
NBQX
|
|
118876-58-7
|